The World Health Organization declared the outbreak a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020.On 31 December 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on 7 January 2020 and was temporarily named “2019-nCoV”.Bereavement, isolation, loss of income and fear are triggering mental health conditions or exacerbating existing ones. Many people may be facing increased levels of alcohol and drug use, insomnia, and anxiety.
Meanwhile, COVID-19 itself can lead to neurological and mental complications, such as delirium, agitation, and stroke. People with pre-existing mental, neurological or substance use disorders are also more vulnerable to SARS-CoV-2 infection ̶ they may stand a higher risk of severe outcomes and even death.
influenza and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. This Emergency Use Authorized (EUA) multiplex PCR test is specifically designed to detect and differentiate between multiple respiratory viruses as the ongoing COVID-19 pandemic overlaps with respiratory virus season. The test uses an assay design with two SARS-CoV-2 targets to compensate for emerging variants and mutations and help provide confidence in results.
Answers & Comments
Answer:
The World Health Organization declared the outbreak a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020.On 31 December 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on 7 January 2020 and was temporarily named “2019-nCoV”.Bereavement, isolation, loss of income and fear are triggering mental health conditions or exacerbating existing ones. Many people may be facing increased levels of alcohol and drug use, insomnia, and anxiety.
Meanwhile, COVID-19 itself can lead to neurological and mental complications, such as delirium, agitation, and stroke. People with pre-existing mental, neurological or substance use disorders are also more vulnerable to SARS-CoV-2 infection ̶ they may stand a higher risk of severe outcomes and even death.
Oct 5, 2020
Answer:
influenza and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. This Emergency Use Authorized (EUA) multiplex PCR test is specifically designed to detect and differentiate between multiple respiratory viruses as the ongoing COVID-19 pandemic overlaps with respiratory virus season. The test uses an assay design with two SARS-CoV-2 targets to compensate for emerging variants and mutations and help provide confidence in results.
Explanation:
Ez points